Acute Arrhythmias General Flashcards
ACLS Algorithm for Algorithm for Pulseless VT or VF
Defibrillation, CPR 2 mins (up to 2 times) then epinephrine 1 mg IV/IO q3-5 min, defibrillation, amiodarone 300 mg IV/IO × 1; may repeat at 150-mg bolus × 1; lidocaine may also be considered
ACLS Algorithm for Asystole or PEA
CPR 2 mins then epinephrine 1 mg IV/IO q3-5 min
If no IV/IO access in ACLS
endotracheal administration of epinephrine, lidocaine, and atropine is allowed at 2–2.5 times the recommended IV/IO dose.
Dilute this dose with 5–10 mL of sterile water or normal saline
Targeted Temperature Management indication and goal
Indicated in adult patients who are comatose in whom return of spontaneous circulation (ROSC) has been achieved after cardiac arrest
Goal temperature: 32°C–36°C for At least 24 hours after achieving the goal temperature
Agents for shivering during TTM
meperidine, buspirone, clonidine, dexmedetomidine, and neuromuscular blocking agents.
Symptomatic Bradycardia 1st Line Agent
If unstable, atropine 1 mg every 3–5 minutes (maximum dose 3 mg). (Note: Unstable = hypotension, acutely altered mental status, signs of shock, ischemic chest discomfort, acute HF)
Symptomatic Bradycardia 2nd Line Agents
If atropine fails, transcutaneous pacing, dopamine 5–20 mcg/kg/minute, or epinephrine 2–10 mcg/minute
Types of Stable Symptomatic Tachycardia
Narrow complex Regular ventricular rhythm: Supraventricular tachycardia (SVT) or sinus tachycardia likely
Irregular (narrow complex) ventricular rhythm: AF (or possibly atrial flutter)
Wide-complex tachycardia (QRS greater than 120 milliseconds): Usually ventricular arrhythmias
Narrow-complex Regular ventricular rhythm therapy
Vagal maneuvers or adenosine 6-mg intravenous push, followed by a 20-mL saline flush,
then a 12-mg intravenous push (may repeat once)
Rapid push followed by elevation of arm to increase circulation
Adenosine for Tachycardia Dose Adjustments
Larger doses may be needed in patients taking theophylline or caffeine.
Initial dose should be reduced to 3 mg in patients taking dipyridamole or carbamazepine and in patients after heart transplantation, and when the drug is being given by central access.
Adenosine for Tachycardia Cautions
Use adenosine cautiously in severe CAD.
should not be given to patients with asthma.
do Not give for unstable or for irregular or polymorphic wide-complex tachycardias because it can cause degeneration to ventricular fibrillation (VF).
Irregular (narrow complex) ventricular rhythm initial therapy
General management should focus on control of the rapid ventricular rate.
Usually non-dihydropyridine CCBs (diltiazem, verapamil) or β-blockers; digoxin sometimes useful
Atrial fibrillation up to 7 days therapy
either elective direct current conversion or chemical cardioversion Flecainide, dofetilide, propafenone, ibutilide, or amiodarone (proven efficacy)
Atrial fibrillation greater than 7 days therapy
administer either elective direct current conversion or chemical cardioversion with dofetilide, amiodarone, or ibutilide (proven efficacy)
Wide-complex tachycardia therapy
Consider adenosine only if regular and monomorphic.
Intravenous procainamide, amiodarone (or sotalol); lidocaine second line